U.S. Packaging Stock News

TransMedics Group FY 2025 earnings snapshot TransMedics Group (TMDX) closed FY 2025 with fourth quarter revenue of US$160.8 million and basic EPS of US$3.08, alongside trailing twelve month revenue of US$605.5 million and EPS of US$5.60 that frame a much larger full year earnings base. Over the past few quarters, the company has seen revenue range from US$143.5 million to US$160.8 million while quarterly EPS moved between US$0.71 and US$3.08. This gives investors a clearer read on how higher...

Vanda Pharmaceuticals (VNDA) is back on investors’ radar after the U.S. Food and Drug Administration approved BYSANTI tablets for bipolar I disorder and schizophrenia, while an earlier imsidolimab filing for generalized pustular psoriasis also progresses through review. See our latest analysis for Vanda Pharmaceuticals. The recent FDA approvals and filings have coincided with sharp share price moves, with a 37.31% 7 day share price return and 56.23% 90 day share price return, while the 1 year...

On February 17, 2026, Sana Biotechnology appointed Brian Piper, M.B.A., as Chief Financial Officer, Executive Vice President, Treasurer, and Principal Financial Officer, ending CEO Steven Harr’s tenure as acting Principal Financial Officer. The move brings a veteran finance leader with extensive public biopharma and IPO experience into Sana’s top ranks, potentially reshaping how the company approaches capital allocation and investor engagement. We’ll explore how bringing in an experienced...

Textron (NYSE:TXT) has declared a quarterly dividend to be paid to shareholders. The company has also filed a shelf registration that would allow it to issue various types of securities in the future. These moves affect both near term shareholder returns and the company’s potential options for raising capital. Textron, the parent company behind businesses in aviation, defense and industrial products, is updating its financial toolkit at the same time it is returning cash to investors. The...

Recent share performance and business snapshot Rexford Industrial Realty (REXR) has seen its share price move within a mixed range recently, with a small gain of 0.6% over the past day and roughly flat performance over the past week. Over a month, the stock shows a 5.2% decline, widening to a 10.3% decline over the past 3 months. On a 1 year view, the total return stands at a 3.5% decline, while the 3 year total return reflects a 30.2% decline. In the context of this share performance, the...

In its recently reported fiscal Q1, Griffon Corporation delivered results that exceeded expectations, advanced a new joint venture between AMES North America and Venanpri Tools to build a global hand tools and home organization platform, and continued returning cash through share repurchases and its 58th consecutive quarterly dividend. An interesting angle for investors is how Griffon is pairing portfolio reshaping through the AMES–Venanpri joint venture with ongoing buybacks and regular...

Oceaneering International, Inc. recently reported fourth-quarter 2025 sales of US$668.57 million and net income of US$177.65 million, issued 2026 earnings guidance, completed a US$160.87 million share repurchase program, and is presenting at The THRIVE Energy Conference in Houston on 26 February 2026. The combination of strong year-on-year profit growth, ongoing capital returns through buybacks, and increased investor outreach highlights how management is emphasizing both operational...

If you are wondering whether Tutor Perini’s recent share price moves still leave room for value, this breakdown is designed to help you make sense of what the current price might be offering. The stock last closed at US$86.10, with returns of 6.2% over 7 days, 11.3% over 30 days, 24.2% year to date, 272.4% over 1 year, and a very large 3 year return that is close to 10x, along with a 431.3% 5 year return. Recent news around Tutor Perini has mainly focused on its position in large...

Abbott Laboratories (NYSE:ABT) is acquiring cancer diagnostics company Exact Sciences in a deal financed by a US$20b bond sale. The transaction marks Abbott's entry into oncology diagnostics, expanding its presence in higher growth testing and screening markets. The large bond issuance is set to reshape Abbott's capital structure and raises fresh questions about risk, return and balance sheet flexibility. Abbott Laboratories, trading at around US$114.76, is moving beyond its traditional...

CCC Intelligent Solutions Holdings (CCCS) closed FY 2025 with Q4 revenue of US$277.9 million and basic EPS of US$0.01, while trailing twelve month figures show revenue of US$1.1 billion and basic EPS of essentially breakeven at US$0.00. Over recent quarters the company has seen revenue move from US$246.5 million in Q4 2024 to US$277.9 million in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of US$0.02. For investors, the latest print puts the spotlight squarely on...

If you are wondering whether Novo Nordisk’s recent share price slump has created a potential opportunity or a value trap, you are in the right place. The stock last closed at US$38.16, after declines of 22.5% over 7 days, 40.4% over 30 days, and 27.2% year to date, with a 56.5% decline over 1 year and a softer 44.6% return over 3 years compared to a 13.5% gain over 5 years. These moves come as Novo Nordisk remains in the spotlight for its role in weight management and diabetes treatments...

What Sify Technologies (SIFY) Investors Might Be Watching Now Sify Technologies (SIFY) has quietly caught investor attention after a very large 1 year total return of 238%, alongside an 81% gain over the past month and 48% over the past 3 months. See our latest analysis for Sify Technologies. With the share price now at US$16.20, Sify Technologies has moved sharply over the past year, as a very large 1 year total shareholder return contrasts with a shorter term share price pullback and...

If you are wondering whether Kosmos Energy is still attractively priced after recent moves, this article walks through what the numbers actually say about its current value. The stock last closed at US$2.09, with returns of 22.9% over the past week, 64.6% over the past month and 134.1% year to date, while the 1 year, 3 year and 5 year returns stand at 21.1% decline, 72.9% decline and 35.9% decline respectively. Recent price action has come alongside ongoing investor interest in the US energy...

Rocky Brands (RCKY) FY 2025 earnings snapshot Rocky Brands (RCKY) closed FY 2025 with fourth quarter revenue of US$139.7 million and basic EPS of US$0.87, supported by trailing twelve month revenue of US$482.0 million and EPS of US$2.98 as the latest earnings release hit the tape. The company has seen quarterly revenue move from US$128.1 million and EPS of US$0.64 in Q4 2024 to US$139.7 million and US$0.87 in Q4 2025. Net profit margin over the last 12 months sits at 4.6% compared with 2.5% a...

Pinterest (NYSE:PINS) is overhauling its sales and go to market approach, with management spotlighting new monetization efforts. The company is bringing in new board members to deepen its commerce and advertising capabilities. Leadership is positioning these changes as a pivot that could reshape how Pinterest turns user engagement into revenue. Pinterest sits at the intersection of visual discovery, shopping intent, and digital advertising. This keeps it closely linked to how brands spend...

eToro Group (NasdaqGS:ETOR) released new survey findings on Gen Z and millennial retail investors. The survey shows younger investors are spreading capital across bonds, foreign equities, real estate, cryptocurrencies, and commodities. The results point to broader diversification beyond the meme stock trading that drew attention in earlier years. eToro operates as a multi asset investing platform, giving retail investors access to a wide range of securities and asset classes in a single...

Why Palvella Therapeutics Has Caught Investor Attention Recent trading in Palvella Therapeutics (PVLA) has drawn attention after a sharp share price move, with the stock closing at US$128.60 and posting very large 1 year total returns. That type of performance, together with reported annual revenue growth of 63.12% and net income growth of 54.52% on a net loss of US$32.37 million, is prompting investors to reassess how they view this clinical stage biopharmaceutical name. See our latest...

Veracyte, ticker NasdaqGM:VCYT, plans to present more than 15 abstracts from its urology portfolio at the 2026 ASCO Genitourinary Cancers Symposium. The company is preparing to launch its TrueMRD test for muscle invasive bladder cancer and continues to build out its broader genomic testing offerings. Veracyte enters this news cycle with its shares at $35.72 and a mixed return profile, including a 50.7% gain over three years alongside a 15.7% decline year to date and a 12.0% decline over the...

AXIS Capital Holdings (NYSE:AXS) announced the retirement of board member Thomas Ramey. His retirement represents a change in the company’s board-level governance structure. For you as an investor, board changes at an insurer like AXIS Capital Holdings matter because they sit close to decisions on risk appetite, capital allocation and long term priorities. The company operates in specialty insurance and reinsurance, areas that can be influenced by evolving regulation and changing views on...

If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly. The stock has seen a 21.3% decline over the last 30 days and is down 22.3% over the past year, which may have shifted how the market views its growth potential and risk profile. Recent coverage has focused on Veeva Systems' role as a key software provider to life sciences companies and how its customer relationships...

AMC Entertainment Holdings (AMC) is back in focus after Muvico, a wholly owned subsidiary, launched a US$1.73b first lien notes offering tied to a new US$750m term loan and broader refinancing plans. See our latest analysis for AMC Entertainment Holdings. That refinancing announcement lands after a tough stretch for holders, with the share price at US$1.16 and recent moves including a 22.15% 30 day share price decline and a 64.42% 1 year total shareholder return loss, suggesting momentum has...

WaterBridge Infrastructure (NYSE:WBI) has announced the initiation of its first quarterly dividend, marking a new approach to capital returns. The company has also launched the open season for its Speedway Phase II Pipeline project, inviting commercial commitments for new capacity. Both announcements were released together as part of a broader update on corporate priorities and capital allocation. For investors following NYSE:WBI, these developments relate directly to how the company is...

On February 19, 2026, Zurn Elkay Water Solutions’ subsidiaries entered into Amendment No. 3 to their first lien credit agreement, refinancing existing revolving borrowings, expanding the revolving credit facility from US$200,000,000 to US$550,000,000, and extending the facility’s maturity to February 19, 2031. The revised agreement, which ties interest margins and fees to net first lien leverage and boosts remaining borrowing capacity to US$540,100,000, materially increases Zurn Elkay’s...

Sprouts Farmers Market appointed Amanda Rassi as its first chief customer officer and Don Clark as chief merchandising officer. The leadership changes signal a fresh focus on customer engagement, personalization and merchandising across the business. Investors are watching how the new C-suite structure will influence shopper loyalty and sales trends. Sprouts Farmers Market (NasdaqGS: SFM) is entering this leadership reset with a share price of $73.73. The stock has seen a 9.0% return over...